首页 › 结直肠癌 › 阿肯色州 › Springdale
Springdale AR 结直肠癌临床试验
5项针对 结直肠癌的研究正在 Springdale及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
招募中3 期
- Highlands Oncology Group - Springdale /ID# 279444, Springdale
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, Rogers · 距离 10 英里
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
招募中3 期
- Highlands Oncology Group, Springdale
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
招募中3 期
- Highlands Oncology Group, Springdale
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
招募中2/3 期
- Highlands Oncology Group, Springdale
其他城市的 结直肠癌试验
- Houston, TX102 项研究
- New York City, NY78 项研究
- Nashville, TN69 项研究
- Boston, MA63 项研究
- Los Angeles, CA59 项研究
- Arlington, VA52 项研究
- St. Louis, MO50 项研究
- San Antonio, TX46 项研究
- Philadelphia, PA44 项研究
- Grand Rapids, MI40 项研究
- Baldwin Park, CA37 项研究
- Chicago, IL34 项研究
Springdale的其他研究
- 非小细胞肺癌15 项研究
- 精神分裂症7 项研究
- 肺癌6 项研究
- 转移性癌症6 项研究
- 乳腺癌5 项研究
- 癌症（所有类型）5 项研究
- 重度抑郁症5 项研究
- 膀胱癌4 项研究
- 抑郁症4 项研究
- 食管癌3 项研究
- 躁狂症3 项研究
- 头颈鳞状细胞癌3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。